Ultragenyx Pharmaceutical | Capitale Ordinario





Capitale Ordinario Cambiamento Data
Acadia Pharmaceuticals USD 168.71M 104K 2025-09
Agios Pharmaceuticals USD 58.45M 169K 2025-12
Alnylam Pharmaceuticals USD 132.38M 585K 2025-12
BioCryst Pharmaceuticals USD 1.9M 3K 2023-09
BioMarin Pharmaceutical USD 192.1M 97K 2025-09
Esperion Therapeutics USD 112K 11K 2023-09
Immunic USD 8K 4K 2024-06
Insmed USD 214.26M 1.67M 2025-12
Ionis Pharmaceuticals USD 161.14M 160.98M 2025-09
Karyopharm Therapeutics USD 13K 0 2024-09
Kyowa Hakko Kirin JPY 523.49M 2K 2025-12
MacroGenics USD 63.26M 62.63M 2025-09
Moderna USD 391M 2M 2025-09
Neurocrine Biosciences USD 100.1M 400K 2025-12
PTC Therapeutics USD 81.47M 1.54M 2025-12
Puma Biotechnology USD 5K 0 2024-06
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Sarepta Therapeutics USD 104.77M 7.06M 2025-09
Ultragenyx Pharmaceutical USD 96.44M 88K 2025-09
Vertex Pharmaceuticals USD 254M 0 2025-12
Xoma USD 87K 1000 2024-06


Ultragenyx Pharmaceutical Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.